Monday, 13 April 2026
  
Login

Australia's most trusted
source of pharma news

Monday, 13 April 2026
IQVIA
IQVIA
Much-loved CEO suddenly passes

Peak patient advocacy group has announced the 'sudden, devastating' passing of its much-loved former CEO, prompting an outpouring of sadness and tributes.

Cheaper meds? Not for everybody
Survey reveals more than two in five voting-age Australians have been prescribed medicines that are not subsidised on the PBS
TODAY
8 deaths overseas but no TGA alert
The FDA and EMA are reconsidering this rare disease drug, but the TGA isn't following suit. Find out why
TODAY
Novartis leader nabs GM role
This well-known industry executive has clearly impressed earning a promotion to a country leadership role
10 April
Who's joined the TGA's review list?
Five drug applications were accepted for review in February, including new indications for two big products
10 April
$210K tit-for-tat Aussie Code fines
Two companies have been fined in a double whammy claim and counterclaim for breaching the MA Code of Conduct
9 April
Meet industry's $50M-a-year Boss
This CEO has notched some impressive milestones for his company and he's been handsomely rewarded for his efforts
9 April
Latest Jobs
New Medical Affairs leader named
Heading the country medical affairs team as his new employer looks to bring an anticipated blockbuster to the Aussie market
TODAY
Takeda snags former Sanofi market
Takeda moves into a market formerly held by Sanofi while yet another company registers a biosimilar of a J&J blockbuster
TODAY Approvals Action
Double-whammy Code breach fine
ICYMI: Two companies slapped with fines for breaching the Aussie Code of Conduct plus the other most popular stories this week
10 April Your Week in 5 Minutes
New battle in obesity kicks off
FDA approves Lilly's obesity pill putting it in a head-to-head battle with Novo Nordisk... and the drug's new trade name is finally out
10 April
Pharmac funds time-saving meds
Newly announced funding for cancer drugs, and an antiviral, are expected to reduce the time patients need to be in hospital
10 April
Marketers 'not quite up to notch'
Survey finds 65 per cent of HCPs have reduced or stopped engagement with a pharma due to poor digital experiences
9 April
Pharmacy chain dominates market
New rankings across the Australian pharmacy chain market have been released revealing who's on top... including a surprise achiever
9 April
Multiple roadblocks for IBD drugs
Despite a high disease burden and high cost to the health system, new drugs to treat IBD aren't landing in Australia, according to patients
9 April
Local exec scores GM ANZ role
Second-ever General Manager for Australia and New Zealand appointed after the founding GM, Michael Azrak, jumped to Novo Nordisk
8 April
Trump tariffs unleash hidden chaos
The US President threw a fox into the Easter Bunny hutch over the Easter Long Weekend and Big Pharma could pay the price
8 April
What Chat says about your drugs
AI answer engines are delivering medical info about particular products that are alarming and companies are in the dark
8 April
Lift-off for Australian-made drug
Prescription medicine developed and manufactured in Australia officially launched as the only TGA-registered treatment of its kind
8 April
SOS distress call for PBS listing
Only three months remaining until the PBAC considers this pharma's revised proposal for an expanded PBS listing for younger children
8 April
Four brands hit with price cuts
April has brought first new brand competition for four drugs, each hit with a 25 per cent statutory reduction in price
7 April
PiF Jobs
PiF Jobs
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.